|Articles|June 1, 2014
- Applied Clinical Trials-06-01-2014
- Volume 23
- Issue 6
ACT cover
S
Advertisement
Cover
Articles in this issue
about 12 years ago
Three-Pronged Approach to Optimizing Trial Monitoringabout 12 years ago
Half of All Drugs Today are Developed Through Collaborationsabout 12 years ago
Event Examines Key Clinical Trial Adaptation Trendsabout 12 years ago
Policymakers Seek New Ways to Streamline R&D and Approvalabout 12 years ago
Rebranding 'Risk-Based Monitoring'about 12 years ago
Engaging Tomorrow's Volunteers Through Museum Learningabout 12 years ago
Questions and Hopes on New EU Drug Legislationabout 12 years ago
The Metrics Behind High Performing Study Startupsabout 12 years ago
Enhancing Trial Enrollment Through 'Goal Programming'about 12 years ago
Shifting Monitoring Paradigms: Challenges and OpportunitiesAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
Bringing the Voice of Clinical Practice and Patients into Drug Development
5